tradingkey.logo

Accuray Inc

ARAY
查看详细走势图
0.907USD
+0.019+2.16%
收盘 12/19, 16:00美东报价延迟15分钟
102.80M总市值
亏损市盈率 TTM

Accuray Inc

0.907
+0.019+2.16%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+2.16%

5天

-14.39%

1月

-13.57%

6月

-25.61%

今年开始到现在

-54.17%

1年

-50.95%

查看详细走势图

TradingKey Accuray Inc股票评分

单位: USD 更新时间: 2025-12-19

操作建议

Accuray Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名85/208位。机构持股占比非常高,近一月多位分析师给出公司评级为强力买入。最高目标价3.88。中期看,股价处于下降通道。近一个月,市场表现较差,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Accuray Inc评分

相关信息

行业排名
85 / 208
全市场排名
208 / 4582
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 2 位分析师
强力买入
评级
3.875
目标均价
+292.13%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Accuray Inc亮点

亮点风险
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
估值高估
公司最新PE估值-5.73,处于3年历史高位
机构减仓
最新机构持股79.19M股,环比减少0.02%
PRFDX持仓
明星投资者PRFDX持仓,最新持仓市值10.25K

Accuray Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Accuray Inc简介

Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
公司代码ARAY
公司Accuray Inc
CEOLa Neve (Stephen R)
网址https://www.accuray.com/

常见问题

Accuray Inc(ARAY)的当前股价是多少?

Accuray Inc(ARAY)的当前股价是 0.907。

Accuray Inc的股票代码是什么?

Accuray Inc的股票代码是ARAY。

Accuray Inc股票的52周最高点是多少?

Accuray Inc股票的52周最高点是2.950。

Accuray Inc股票的52周最低点是多少?

Accuray Inc股票的52周最低点是0.885。

Accuray Inc的市值是多少?

Accuray Inc的市值是102.80M。

Accuray Inc的净利润是多少?

Accuray Inc的净利润为-1.59M。

现在Accuray Inc(ARAY)的股票是买入、持有还是卖出?

根据分析师评级,Accuray Inc(ARAY)的总体评级为--,目标价格为3.875。

Accuray Inc(ARAY)股票的每股收益(EPS TTM)是多少

Accuray Inc(ARAY)股票的每股收益(EPS TTM)是-0.158。
KeyAI